Related Experiment Video
Updated: Mar 15, 2026
02:28
Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
993
Recent Advances in Psoriatic Arthritis from Obscurity to Prominence
1Ex-senior Resident in Rheumatology.
The Journal of the Association of Physicians of India
|September 10, 2016
Summary
Psoriatic arthritis (PsA) research has advanced significantly due to genetic insights and improved treatments. This overview covers the immunopathology, genetics, and therapies for PsA.
Area of Science:
- Rheumatology
- Immunology
- Genetics
Background:
- Psoriatic arthritis (PsA) was historically understudied due to limited understanding of its immunopathology and treatment options.
- Recent advancements have repositioned PsA as a key area of research in inflammatory arthritis.
Purpose of the Study:
- To provide a comprehensive overview of psoriatic arthritis.
- To highlight recent progress in understanding PsA's genetic susceptibility and immunopathogenesis.
- To discuss the availability of effective therapeutic strategies for PsA.
Main Methods:
- Review of current scientific literature on psoriatic arthritis.
- Analysis of genetic susceptibility associations.
- Examination of immunopathogenic mechanisms.
- Evaluation of current and emerging treatment options.
Main Results:
- Elucidation of genetic factors contributing to PsA development.
- Improved understanding of the underlying immunopathogenesis of PsA.
- Development and availability of effective therapies for managing PsA.
Conclusions:
- Psoriatic arthritis is now a well-understood inflammatory condition with promising therapeutic avenues.
- Advances in genetics and immunology have transformed the study and treatment of PsA.
- The current landscape of PsA offers better management and prognosis for affected individuals.
Related Concept Videos
01:11Genome-wide Association Studies-GWAS
16.5K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
16.5K
01:21EPS and iPS Cells in Disease Research
3.5K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.5K
01:22iPS Cell Differentiation
3.3K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.3K
01:20The JAK-STAT Signaling Pathway
13.6K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
13.6K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
895
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
895
01:24T Cell Types and Functions
3.1K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.1K